Skip to main content
Premium Trial:

Request an Annual Quote

InteRNA Joins RNA Silencing Research Consortium

NEW YORK (GenomeWeb News) – Dutch firm InteRNA Technologies today said that it has joined the SIROCCO research consortium, a group of 25 labs and companies from 10 countries studying the use of RNA silencing for therapeutic applications, such as treating cancer.
SIROCCO stands for “Silencing RNAs: organizers and coordinators of complexity in eukaryotic organisms.”
InteRNA said that it will focus its efforts as part of the consortium on discovery, data mining, and development of diagnostic miRNA and other small RNA profiles through next-generation sequencing in combination with its own small RNA bioinformatics products.
The firm will participate in the remaining two and a half years of the project, which was funded with €11.8 million ($15 million) under the EU Sixth Framework Programme.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more